Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a national provider of premium body contouring procedures, centered on its proprietary AirSculpt treatment. The company’s press releases and SEC filings provide regular updates on its operating performance, capital structure, leadership changes and strategic initiatives in the aesthetics and body contouring market.
On this news page, readers can follow AirSculpt’s quarterly earnings announcements, where the company reports case volumes, revenue trends, net income or loss, Adjusted EBITDA and liquidity metrics. These releases often include management commentary on transformation efforts, growth opportunities, margin improvement, debt reduction and the broader market context for aesthetics, including the impact of GLP‑1 use.
Investors can also track news related to AirSculpt’s capital markets activity, such as underwritten public offerings of common stock conducted under an effective shelf registration statement, and subsequent voluntary prepayments of term loan debt. The company has highlighted how these actions affect its capital structure, revolving credit facility availability and financial flexibility.
Governance and leadership developments are another key theme in AirSculpt news. Recent items include the appointment of a new Chief Financial Officer, the election of a Non-Executive Chairman of the Board, board and executive departures, and participation in investor conferences such as the Sidoti Micro Cap Conference. Each announcement is accompanied by context on the individual’s background or the company’s investor relations strategy.
By reviewing this curated stream of company-issued news, followers of AIRS stock can see how AirSculpt presents its business trajectory, risk considerations, non-GAAP metrics and strategic priorities over time. Bookmark this page to access the latest official updates, earnings dates, conference call details and other material disclosures from AirSculpt Technologies.
AirSculpt Technologies (NASDAQ: AIRS) announced it will release its Q3 results on December 3, 2021, before market open, followed by a conference call at 8:30 a.m. ET. Investors can dial in at 1-877-407-9716 for the live call or access a replay using the code 13725116. The replay will be available until December 10, 2021. AirSculpt specializes in body contouring procedures through its proprietary AirSculpt® method, focusing on delivering a high-quality consumer experience.
AirSculpt Technologies has announced its initial public offering (IPO) of 7,000,000 shares at $11.00 per share. The offering consists of 2,173,913 shares issued by the company and 4,826,087 shares sold by existing stockholders. Underwriters have a 30-day option to buy an additional 1,050,000 shares. The shares are set to trade on NASDAQ under the symbol AIRS on October 29, 2021, with expected closing on November 2, 2021.
AirSculpt Technologies has announced the commencement of its initial public offering (IPO) roadshow, aiming to raise funds by offering 1,562,500 shares of common stock, alongside 8,437,500 shares from existing stockholders. The IPO price is set between $15.00 and $17.00 per share, with an option for underwriters to purchase up to 1,500,000 additional shares. The company intends to list its stock on Nasdaq under the symbol 'AIRS'. Morgan Stanley and Piper Sandler are leading the offering, with a registration statement already filed with the SEC but not yet effective.